Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]

  • Awaiting development
  • GID-TA11565
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators